BillionToOne

📍 Menlo Park, United States🗓 Founded 2016👥 702 employees💰 Last funded May 2024
BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible. Our proprietary molecular counting platform can accurately count DNA molecules at the single-count level to help improve disease detection.
10
Total investors
3
Early stage
4
Mid stage
3
Late stage
2016
Founded
Investor geography3 countries
United States
7
United Kingdom
2
Turkey
1
Investor activity2016–2024 · investors recorded per year
201612017220193202012022220241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in BillionToOne?
BillionToOne has 10 investors on record on gritt.io, including 3 early-stage backers, 4 mid-stage and 3 late-stage investors.
When did BillionToOne last raise funding?
The most recent investment in BillionToOne recorded on gritt.io was in May 2024.
When was BillionToOne founded?
BillionToOne was founded in 2016.
What industry is BillionToOne in?
BillionToOne operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is BillionToOne based?
BillionToOne is headquartered in Menlo Park, United States.